Published: November 9, 2026
India’s pharmaceutical sector is an important part of the country’s trade and healthcare supply landscape. The Press Information Bureau reported that pharmaceutical exports reached USD 30.47 billion in FY 2024–25, representing 9.4% growth over the previous year.
What export growth can mean
Export growth reflects demand across international markets and the work involved in manufacturing, quality systems, regulatory documentation and dependable logistics. The PIB release notes that Indian medicines reach more than 200 markets. Each destination has its own requirements, so market access depends on meeting applicable standards and completing the required approvals and documentation.
Supply opportunities and preparation
For companies across the sector, international supply opportunities depend on reliable sourcing, consistent product quality, traceable records and the ability to respond to market-specific rules. Export expansion therefore involves coordination among manufacturers, exporters, regulators and logistics partners, rather than demand alone.
The figures describe the national industry and do not indicate that any particular business exports medicines or holds a specific approval.
Source: Press Information Bureau, Ministry of Commerce & Industry, release published February 21, 2026. Read Original Source.
